Livedo reticularis
Ko te Livedo reticularis he kitenga kiri noa kei roto i te tauira ngongo ngongo kua kotingotingo te ahua o te miro he papura o te kiri. Ka kaha ake pea na te pa ki te makariri, ka puta i te nuinga o nga wa i nga pito o raro. Na te hekenga o te rere o te toto i roto i nga arterioles e tuku ana i nga capillaries kiri, ka puta te toto deoxygenated e whakaatu ana he ahua kikorangi. Ka puta tuarua tenei na te hiperlipiidemia (hyperlipidemia), te ngā āhuatanga hematologic microvascular (microvascular hematologic), te kōmaka toto (anemia), te ngoikore o te kai, te ngā mate hipere me ngā mate ā-āhua (autoimmune diseases), me te rāua rongoā (drugs) me ngā matū kino (toxins).
☆ AI Dermatology — Free Service
I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
Lesion na te kino infrarenal aortoiliac stenosis.
relevance score : -100.0%
ReferencesKo te Livedo reticularis (LR) he ahua kiri e tohuhia ana e te ahua rangitahi, ka roa ranei, he kotingotingo, he whero-puru ki te papura, he tauira kupenga. Ko te nuinga o nga wa ka pa ki nga wahine o waenga-pakeke, a, ko te nuinga o te waa kaore he tohu. I tetahi atu taha, ko te livedo racemosa (LRC) he ahua kino ake e hono ana ki te antiphospholipid antibody syndrome.
Livedo reticularis (LR) is a cutaneous physical sign characterized by transient or persistent, blotchy, reddish-blue to purple, net-like cyanotic pattern. LR is a benign disorder affecting mainly middle-aged females, whereas livedo racemosa (LRC) is pathologic, commonly associated with antiphospholipid antibody syndrome.
Livedo reticularis (LR) is a cutaneous physical sign characterized by transient or persistent, blotchy, reddish-blue to purple, net-like cyanotic pattern. LR is a benign disorder affecting mainly middle-aged females, whereas livedo racemosa (LRC) is pathologic, commonly associated with antiphospholipid antibody syndrome.
